Tenet Healthcare Form 144 filed for sale of 13,322 common shares

Tenet Healthcare (THC) filed a Form 144 indicating an intended sale of 13,322 shares of common stock through Fidelity Brokerage Services LLC on or about 11/06/2025, to be sold on the NYSE.

Rhea-AI Filing Summary

Tenet Healthcare (THC) filed a Form 144 indicating an intended sale of 13,322 shares of common stock through Fidelity Brokerage Services LLC on or about 11/06/2025, to be sold on the NYSE. The filing lists an aggregate market value of $2,732,412.25 for the proposed sale.

The shares reflect restricted stock that vested on multiple dates and were received as compensation from the issuer. Shares outstanding were 87,885,000; this is a baseline figure, not the amount being sold.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Tenet Healthcare (THC) disclose in this Form 144?

An intended sale of 13,322 common shares with an aggregate market value of $2,732,412.25.

When is the approximate sale date for the THC shares?

The filing lists an approximate sale date of 11/06/2025.

Which broker is listed for the proposed THC share sale?

The broker is Fidelity Brokerage Services LLC.

On which exchange are the THC shares to be sold?

The filing names the NYSE.

How were the shares to be sold acquired?

They were acquired via restricted stock vesting on dates including 02/23/2024, 02/24/2024, 03/01/2024, 02/23/2025, 02/28/2025, and 03/01/2025 as compensation.

How many THC shares are outstanding per the filing?

The filing lists 87,885,000 shares outstanding.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 11/06/2025 - 12:39 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001558231
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	TENET HEALTHCARE CORP
SEC File Number	001-07293
Address of Issuer	14201 DALLAS PARKWAY DALLAS TEXAS 75254
Phone	469-893-2200
Name of Person for Whose Account the Securities are To Be Sold	Ramsey R. Scott
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	13322	2732412.25	87885000	11/06/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/23/2024	Restricted Stock Vesting	Issuer			638	02/23/2024	Compensation
Common	02/24/2024	Restricted Stock Vesting	Issuer			4628	02/24/2024	Compensation
Common	03/01/2024	Restricted Stock Vesting	Issuer			1058	03/01/2024	Compensation
Common	02/23/2025	Restricted Stock Vesting	Issuer			5529	02/23/2025	Compensation
Common	02/28/2025	Restricted Stock Vesting	Issuer			620	02/28/2025	Compensation
Common	03/01/2025	Restricted Stock Vesting	Issuer			849	03/01/2025	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	11/06/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Jennifer Ruchti, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Randy S. Ramsey
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)